FeesSafety
Pluang+

Owlting Group secures $5M financing to expand OwlPay payment operations and onboard more customers.

Market News
09 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
Owlting Group secures $5M financing to expand OwlPay payment operations and onboard more customers.

Owlting Group has raised an additional $5 million from The Lind Partners, following a previous $10 million investment, to support the growth of its OwlPay platform. The funds will be used to onboard more enterprise customers, enhance payment liquidity, maintain regulatory licenses, and develop new payment corridors. OwlPay Harbor, the company's stablecoin-based cross-border payment platform, has shown strong growth with over 100 enterprise clients and transactions in about 50 countries. This financing boost aims to convert customer adoption into increased transaction revenue as Owlting scales its commercial operations.

Owlting Group's recent $5 million financing is presented here with Pluang's Financials sector data as context. For readers following this sector, as of Nov 09, 2026 19:13 WIB, 98 of 142 US Financial stocks rose while 18 fell. Notable movers include BMNR at USD 17.88 with a 1-day change of -4.69%, SAN at USD 12.21 up 4.05%, and PURR at USD 8.49 down 3.69%. Typical hold times vary widely, from 6 days for BMNR and PURR to 56 days for SAN.

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
1 hour ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
2 hours ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
2 hours ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
2 hours ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App